ORBi: Browsing ORBi


	References of "Adami, Silvio" in Showing results 1 to 13 of 13 1 Association between changes in bone mineral density and vertebral fracture incidence in untreated postmenopausal women : a 3-year prospective study Bruyère, Olivier ; Roces-Varela, A.; Adami, Silvio et al in Annals of the Rheumatic Diseases (2008, June), 67(Suppl.II), 89 Detailed reference viewed: 10 (6 ULg) Association between changes in bone mineral density and vertebral fracture incidence in untreated postmenopausal women Bruyère, Olivier ; Roces-Varela, A.; Adami, Silvio et al in Osteoporosis International (2008, April), 19(Suppl.1), 199 Detailed reference viewed: 9 (2 ULg) Effects of strontium ranelate on radiographic spinal osteoarthritis progression Bruyère, Olivier ; Delferriere, Danielle; Roux, Christian et al in Arthritis and Rheumatism (2007, September), 56(number 9 (suppl.)), 315 Detailed reference viewed: 11 (4 ULg) Dissociation between bone formation and bone resorption evidenced by changes in biochemical markers of bone turnover in patients treated with strontium ranelate COLLETTE, Julien ; Reginster, Jean-Yves ; Bruyère, Olivier et al in Calcified Tissue International (2007, May), 80(Suppl.1), 120 Detailed reference viewed: 12 (4 ULg) Dissociation between bone formation and bone resorption evidenced by changes in biochemical markers of bone turnover in patients treated with strontium ranelate Collette, Julien ; Reginster, Jean-Yves ; Bruyère, Olivier et al in Osteoporosis International (2007, March), 18(Suppl.1), 125 Detailed reference viewed: 7 (1 ULg) Once-monthly dosing of oral ibandronate is highly efficacious: 2-year results from mobile Reginster, Jean-Yves ; Stakkestad, J. A.; Lorenc, R. et al in Osteoporosis International (2006, March), 17(Suppl.1), 64-65 Detailed reference viewed: 1 (0 ULg) One-year increase in hip (hip or femoral neck) bone mineral density pridicts long-term (3 years) decrease in vertebral fracture incidence in patients treated with strontium ranelate Bruyère, Olivier ; Fardellone, P.; Kaufman, Jean-Marc et al in Osteoporosis International (2006, March), 17(Suppl.1), 96 Detailed reference viewed: 2 (0 ULg) Upper gastrointestinal safety and tolerability profile of once-monthly and daily oral ibandronate is similar in postmenopausal osteoporosis: 1-year results from MOBILE Adami, Silvio; Tanko, L. B.; Nuti, R. et al in Annals of the Rheumatic Diseases (2005, June), 64(Suppl.III), 364 Detailed reference viewed: 4 (1 ULg) Vertebral and non-vertebral anti-fracture efficacy of strontium ranelate in very elderly women with osteoporosis Seeman, E.; Vellas, B.; Meunier, Pierre J et al in Osteoporosis International (2005, March), 16(Suppl.3), 6 Detailed reference viewed: 5 (0 ULg) A novel bisphosphonate dosing regimen: once-monthly oral ibandronate Cooper, C.; Adami, Silvio; Stepan, J. J. et al in Annals of the Rheumatic Diseases (2004, June) Detailed reference viewed: 4 (1 ULg) Strontium ranelate reduces the risk of vertebral and non-vertebral fractures in Caucasian women with postmenopausal osteoporosis Adami, Silvio; Meunier, Pierre J; Devogelaer, Jean-Pierre et al in Osteoporosis International (2004, May), 15(Suppl.1), 93-94 Detailed reference viewed: 5 (3 ULg) Once-weekly alendronate produces a greater decrease in bone resorption than daily risedronate Adami, Silvio; Felsenberg, D.; Hosking, D. et al in Osteoporosis International (2002, November), 13(Suppl.3), 14-15 Detailed reference viewed: 9 (0 ULg) Once weekly alendronate produces a greater decrease in bone resorption than daily risedronate Hosking, D.; Adami, Silvio; Felsenberg, D. et al in Annals of the Rheumatic Diseases (2002, June), 61(Suppl.1), Detailed reference viewed: 18 (9 ULg) 1